# EMS clinical trials: 84 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 84 trials with EMS as lead sponsor, 14 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by EMS: 84 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ems

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 84
- Recruiting or not yet: 14
- Read on: November 19, 2026

## Trials

The 25 newest of 84, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 25, 2026 | NCT07843056 | A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With... | EMS | Phase 2 | Completed | Schizophenia Disorder | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843056) |
| September 22, 2026 | NCT07835074 | A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years | EMS | Phase 3 | Not yet recruiting | Persistent Allergic Rhinitis | 316 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835074) |
| June 19, 2025 | NCT07030101 | A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension | EMS | Phase 3 | Not yet recruiting | Hypertension | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07030101) |
| August 15, 2024 | NCT06555549 | Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain in Primary Dysmenorrhea: a Pilot Study | EMS | Not applicable | Unknown | Primary Dysmenorrhea | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06555549) |
| February 22, 2024 | NCT06272409 | Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. | EMS | Phase 3 | Not yet recruiting | Allergic Rhinitis | 318 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06272409) |
| February 20, 2024 | NCT06268054 | Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea | EMS | Phase 3 | Not yet recruiting | Primary Dysmenorrhea | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06268054) |
| February 20, 2024 | NCT06264414 | Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia | EMS | Phase 3 | Not yet recruiting | Prostatic Hyperplasia, Benign, Erectile Dysfunction | 262 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06264414) |
| February 1, 2024 | NCT06237231 | Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars | EMS | Phase 3 | Not yet recruiting | Moderate Pain, Severe Pain | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06237231) |
| June 2, 2023 | NCT05886088 | Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus | EMS | Phase 3 | Not yet recruiting | Type 2 Diabetes Mellitus | 597 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05886088) |
| April 21, 2023 | NCT05824065 | Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss | EMS | Phase 3 | Not yet recruiting | Female Pattern Baldness | 504 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05824065) |
| April 5, 2023 | NCT05800392 | Efficacy and Safety of DEC103 in Pain Control Associated to Intrauterine Device (IUD) Insertion | EMS | Phase 4 | Completed | Pain | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05800392) |
| March 16, 2023 | NCT05772338 | Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis | EMS | Not applicable | Unknown | Aphthous Stomatitis | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05772338) |
| January 13, 2023 | NCT05684380 | Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) | EMS | Phase 3 | Unknown | Allergic Rhinitis | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05684380) |
| December 7, 2022 | NCT05640232 | Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea | EMS | Phase 3 | Recruiting | Primary Dysmenorrhea | 238 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05640232) |
| September 15, 2022 | NCT05542173 | Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations | EMS | Phase 3 | Unknown | Aphthous Stomatitis | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05542173) |
| July 13, 2022 | NCT05456152 | Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia | EMS | Phase 3 | Unknown | Chronic Insomnia | 358 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05456152) |
| December 3, 2021 | NCT05144360 | Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension | EMS | Phase 3 | Withdrawn | Hypertension Associated, Type II Diabetes Mellitus | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05144360) |
| November 18, 2021 | NCT05125978 | Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain | EMS | Phase 2 | Withdrawn | Pain, Chronic | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05125978) |
| September 22, 2021 | NCT05052879 | Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation | EMS | Phase 3 | Unknown | Erectile Dysfunction, Premature Ejaculation | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05052879) |
| September 2, 2021 | NCT05031481 | Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. | EMS | Phase 2 | Withdrawn | Vulvovaginal Candidiasis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05031481) |
| August 31, 2021 | NCT05028140 | Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus | EMS | Phase 3 | Recruiting | Type II Diabetes | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05028140) |
| July 21, 2021 | NCT04970108 | Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension | EMS | Phase 3 | Withdrawn | Hypertension Associated, Type II Diabetes Mellitus | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04970108) |
| December 17, 2020 | NCT04670666 | Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus | EMS | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04670666) |
| December 17, 2020 | NCT04670653 | Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis | EMS | Phase 3 | Withdrawn | Allergic Rhinitis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04670653) |
| December 14, 2020 | NCT04666714 | Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain | EMS | Phase 3 | Recruiting | Neuropathic Pain | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04666714) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 9 |
| Phase 3 | 68 |
| Phase 4 | 5 |
| Not applicable | 2 |

## By status

| Status | Trials |
| --- | --- |
| Withdrawn | 29 |
| Completed | 28 |
| Unknown | 11 |
| Not yet recruiting | 8 |
| Recruiting | 6 |
| Terminated | 1 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypertension | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Rhinitis, Allergic | 7 |
| Dyslipidemias | 6 |
| Common Cold | 4 |
| Sleep Initiation and Maintenance Disorders | 3 |
| Erectile Dysfunction | 3 |
| Back Pain | 2 |
| Eczema | 2 |
| Dermatitis | 2 |
| Dermatitis, Atopic | 2 |
| Acute Pain | 2 |
| Herpes Simplex | 2 |
| Alopecia | 2 |
| Musculoskeletal Pain | 2 |
| Varicose Veins | 2 |
| Dyspepsia | 2 |
| Pain | 2 |
| Influenza, Human | 2 |
| Asthma | 2 |
| Stomatitis, Aphthous | 2 |
| Prostatic Hyperplasia | 2 |
| Memory Disorders | 1 |
| Herpes Zoster | 1 |
| Herpes Labialis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Fingerprinting services in the United States](https://specstream.ai/data/businesses/fingerprinting-services/united-states)
- [Instrumentation engineers in the United States](https://specstream.ai/data/businesses/instrumentation-engineers/united-states)
- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [Psychiatric hospitals in the United States](https://specstream.ai/data/businesses/psychiatric-hospitals/united-states)
- [Taco restaurants in the United States](https://specstream.ai/data/businesses/taco-restaurants/united-states)
